EUVIMEDEUVIMED entdecken
EditorialKommentar

Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma

Simone Ribero, Pietro Quaglino, Gabriele Roccuzzo iD

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljae092 ↗

Kurz gefasst

Editorial in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Simone Ribero und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsCarcinoma, Squamous CellHumansMalePrognosisFemaleMiddle AgedAgedImmunotherapyDrug EruptionsImmune Checkpoint InhibitorsAntineoplastic Agents, Immunological

Substanzen

Immune Checkpoint InhibitorsAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.

ORCID-Profile: Gabriele Roccuzzo

Zitieren

APA

Ribero, S., Quaglino, P., & Roccuzzo, G. (2024). Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae092

Vancouver

Ribero S, Quaglino P, Roccuzzo G. Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae092

BibTeX
@article{Ribero2024,
  author = {Ribero, Simone and Quaglino, Pietro and Roccuzzo, Gabriele},
  title = {Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljae092}
}
Kostenlos starten →